| is a: | FF:0000423 (human Lymphatic Endothelial cells 6h after VEGFC treatment sample),FF:0000439 (human MCF7 breast cancer cell line 6h after EGF1 treatment sample),FF:0000455 (human MCF7 breast cancer cell line 6h after HRG treatment sample),FF:0000463 (mouse ST2 Mesenchymal stem cells, cells 6hr after adipogenic induction sample),FF:0000478 (mouse ST2 Mesenchymal stem cells, cells 6hr after osteogenic induction sample),FF:0000490 (ST2 Mesenchymal stem cells, cells 6hr after medium change , without induction),FF:0000510 (mouse J2E erythroblastic leukemia line 6hr after treatment with erythropoietin sample),FF:0000526 (human K562 erythroblastic leukemia line 6hr after treatment with hemin sample),FF:0000555 (human Aortic Smooth Muscle cells 6hr after treatment with FGF2 sample),FF:0000565 (human Aortic Smooth Muscle cells 6hr after treatment with IL1b sample),FF:0000579 (human Monocyte-derived macrophages 6h after LPS treatment sample),FF:0000615 (mouse EBF KO HPCs induced to T cell 6h sample),FF:0011446 (CD4-positiveCD25-CD44- naive conventional T cells stimulated with alphaCD3_CD28 - 06hr- (C57BL_6J) sample),FF:0011447 (CD4-positiveCD25-CD44- naive conventional T cells stimulated with alphaCD3_CD28- 06hr- (Balb_cAJcl) sample),FF:11943-126A8 (CD4+CD25+ regulatory T cells, antiCD3 CD28 stimulation, 06hr, pool1 (BalbcA)),FF:11944-126A9 (CD4+CD25+ regulatory T cells, antiCD3 CD28 stimulation, 06hr, pool1 (C57BL 6J)),FF:13544-145H7 (293SLAM rinderpest infection),FF:13545-145H8 (293SLAM rinderpest infection),FF:13546-145H9 (293SLAM rinderpest infection),FF:13556-146A1 (COBL-a rinderpest infection),FF:13557-146A2 (COBL-a rinderpest infection),FF:13558-146A3 (COBL-a rinderpest infection),FF:13568-146B4 (COBL-a rinderpest(-C) infection),FF:13569-146B5 (COBL-a rinderpest(-C) infection),FF:13570-146B6 (COBL-a rinderpest(-C) infection),FF:3569-170A2 (macrophage, TB infection, stimulated BMDM+IFNg(caMph)),FF:3579-170B3 (macrophage, TB infection, stimulated BMDM+IL-13(aaMph), without Mtb),FF:3589-170C4 (macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb),FF:3599-170D5 (macrophage, TB infection, stimulated BMDM+IL-4(aaMph), without Mtb),FF:3641-171A2 (macrophage, TB infection, stimulated BMDM+IFNg(caMph)),FF:3651-171B3 (macrophage, TB infection, stimulated BMDM+IL-13(aaMph), without Mtb),FF:3661-171C4 (macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb),FF:3671-171D5 (macrophage, TB infection, stimulated BMDM+IL-4(aaMph), without Mtb),FF:3706-172C1 (macrophage, TB infection, non-stimulated BMDM, without Mtb) |
|---|
